0001415889-24-004210.txt : 20240216
0001415889-24-004210.hdr.sgml : 20240216
20240216180355
ACCESSION NUMBER: 0001415889-24-004210
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240214
FILED AS OF DATE: 20240216
DATE AS OF CHANGE: 20240216
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lettmann Jason
CENTRAL INDEX KEY: 0001688269
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-39386
FILM NUMBER: 24649910
MAIL ADDRESS:
STREET 1: C/O RA PHARMACEUTICALS, INC.
STREET 2: 87 CAMBRIDGEPARK DRIVE
CITY: CAMBRIDGE
STATE: MA
ZIP: 02140
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC
CENTRAL INDEX KEY: 0001810182
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 850642577
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
BUSINESS PHONE: 650-466-7125
MAIL ADDRESS:
STREET 1: 323 ALLERTON AVENUE
CITY: SOUTH SAN FRANCISCO
STATE: CA
ZIP: 94080
4
1
form4-02162024_110246.xml
X0508
4
2024-02-14
0001810182
ALX ONCOLOGY HOLDINGS INC
ALXO
0001688269
Lettmann Jason
C/O ALX ONCOLOGY HOLDINGS INC.
323 ALLERTON AVENUE
SOUTH SAN FRANCISCO
CA
94080
true
true
false
false
CHIEF EXECUTIVE OFFICER
0
Common Stock
2024-02-14
4
A
0
60000
0
A
167220
D
Employee Stock Option
15.84
2024-02-14
4
A
0
190000
0
A
2034-02-13
Common Stock
190000
190000
D
The reported shares are represented by restricted stock units, or RSUs, which vest in eight equal semiannual installments beginning on August 14, 2024.
Shares subject to the option vest in 48 equal monthly installments beginning on March 14, 2024.
/s/ Peter Garcia, by power of attorney
2024-02-16